Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
S??ren Buus
Affiliation
University of Copenhagen
ORCID
Career Start Year
1974
Papers
320
H Index
71
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36695639
High levels of antibodies 6 months after COVID-19 vaccination in children with severe chronic diseases: A prospective longitudinal case series.
Acta Paediatr
2023
37662376
Coxsackievirus infection induces direct pancreatic β-cell killing but poor anti-viral CD8+ T-cell responses.
bioRxiv
2023
37483599
The structure of songbird MHC class I reveals antigen binding that is flexible at the N-terminus and static at the C-terminus.
Front Immunol
2023
36992095
Efficacy of Phase I and Phase II <i>Coxiella burnetii</i> Bacterin Vaccines in a Pregnant Ewe Challenge Model.
Vaccines (Basel)
2023
35042788
Minimal Information about MHC Multimers (MIAMM).
J Immunol
2022
35453564
Defective Proinsulin Handling Modulates the MHC I Bound Peptidome and Activates the Inflammasome in β-Cells.
Biomedicines
2022
36545256
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade.
Oncoimmunology
2022
36423003
Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from <i>Theileria parva</i> Infected Cells.
Vaccines (Basel)
2022
36330531
HIV specific CD8<sup>+</sup> T<sub>RM</sub>-like cells in tonsils express exhaustive signatures in the absence of natural HIV control.
Front Immunol
2022
36288703
Focused B cell response to recurring gluten motif with implications for epitope spreading in celiac disease.
Cell Rep
2022
33436573
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.
Nat Commun
2021
33789985
Integral Use of Immunopeptidomics and Immunoinformatics for the Characterization of Antigen Presentation and Rational Identification of BoLA-DR-Presented Peptides and Epitopes.
J Immunol
2021
34659264
Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report.
Front Immunol
2021
34561224
CD8<sup>+</sup> T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes.
Diabetes
2021
34835021
Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain.
Viruses
2021
32482711
HLA Class II Specificity Assessed by High-Density Peptide Microarray Interactions.
J Immunol
2020
37427310
Immunoinformatics: Predicting Peptide-MHC Binding.
Annu Rev Biomed Data Sci
2020
33303011
Measles-mumps-rubella vaccine at 6â¿¿months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial.
Trials
2020
32973802
Effector CD8 T Cell-Dependent Zika Virus Control in the CNS: A Matter of Time and Numbers.
Front Immunol
2020
32903714
Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction.
Front Immunol
2020
32928873
Peptides Derived From Insulin Granule Proteins Are Targeted by CD8<sup>+</sup> T Cells Across MHC Class I Restrictions in Humans and NOD Mice.
Diabetes
2020
32983097
A Systematic, Unbiased Mapping of CD8<sup>+</sup> and CD4<sup>+</sup> T Cell Epitopes in Yellow Fever Vaccinees.
Front Immunol
2020
32132233
T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
J Virol
2020
31578220
NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions.
Mol Cell Proteomics
2019
29315598
Improved methods for predicting peptide binding affinity to MHC class II molecules.
Immunology
2018
30078552
Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors.
Cell Metab
2018
30487790
Major TCR Repertoire Perturbation by Immunodominant HLA-B<sup>*</sup>44:03-Restricted CMV-Specific T Cells.
Front Immunol
2018
30547051
Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA.
Mol Ther Methods Clin Dev
2018
30446001
Footprints of antigen processing boost MHC class II natural ligand predictions.
Genome Med
2018
29623081
A New <i>In Vivo</i> Model to Study Protective Immunity to Zika Virus Infection in Mice With Intact Type I Interferon Signaling.
Front Immunol
2018
29429978
Islet-reactive CD8<sup>+</sup> T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors.
Sci Immunol
2018
29167337
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection.
J Virol
2018
28886949
Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs.
Vaccine
2017
28386132
Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination.
Sci Rep
2017
28077675
Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools.
Sci Transl Med
2017
28077659
HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer<sup>+</sup> Gag-Specific CD4<sup>+</sup> T Cells in Chronic Clade C HIV-1 Infection.
J Virol
2017
28095436
ArrayPitope: Automated Analysis of Amino Acid Substitutions for Peptide Microarray-Based Antibody Epitope Mapping.
PLoS One
2017
29435138
Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes.
Oncotarget
2017
29232408
Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations.
PLoS One
2017
29020090
Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificities.
PLoS One
2017
28878089
HLA-B*14:02-Restricted Env-Specific CD8<sup>+</sup> T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection.
J Virol
2017
28589207
Prediction and in vitro verification of potential CTL epitopes conserved among PRRSV-2 strains.
Immunogenetics
2017
28582449
HIV-1 adaptation to NK cell-mediated immune pressure.
PLoS Pathog
2017
28819312
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.
Sci Rep
2017
28686208
Structural Elements Recognized by Abacavir-Induced T Cells.
Int J Mol Sci
2017
26810224
Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.
J Immunol
2016
26572135
A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.
Immunogenetics
2016
27498407
Expanding specificity of class I restricted CD8<sup>+</sup> T cells for viral epitopes following multiple inoculations of swine with a human adenovirus vectored foot-and-mouth disease virus (FMDV) vaccine.
Vet Immunol Immunopathol
2016
27402703
Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.
J Immunol
2016
26886513
Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.
PLoS Negl Trop Dis
2016
1 - 50 of 320
Column Actions
Search
Recommended Authors
Christopher Szeto
La Trobe Institute for Molecular Science, La Trobe University
Career Start Year
2005
Number of shared co-authors
1
David S DeLuca
Hannover Medical School
Career Start Year
2004
Number of shared co-authors
1
Junbao Yang
Benaroya Research Institute
Career Start Year
2003
Number of shared co-authors
1
Florence A Castelli
Universite Paris Saclay
Career Start Year
2002
Number of shared co-authors
0
Ning Jiang
The University of Texas at Austin
Career Start Year
2000
Number of shared co-authors
0
Lindsay G Cowell
University of Texas Southwestern Medical Center
Career Start Year
1998
Number of shared co-authors
3
Erik J Peterson
University of California
Career Start Year
1996
Number of shared co-authors
0
Manish J Butte
University of California Los Angeles
Career Start Year
1994
Number of shared co-authors
0
Vivian H Gersuk
Center for Systems Immunology, Benaroya Research Institute
Career Start Year
1993
Number of shared co-authors
2
Pedro A Lamothe
Allergy and Critical Care Medicine Emory University School of Medicine
Career Start Year
1988
Number of shared co-authors
4
Laura Santambrogio
Weill Cornell School of Medicine
Career Start Year
1988
Number of shared co-authors
0
Christine A Olson
University of California los angeles
Career Start Year
1988
Number of shared co-authors
0
Kanury V S Rao
Translational Health Science and Technology Institute
Career Start Year
1987
Number of shared co-authors
0
Philippe Moingeon
France French Academy of Pharmacy
Career Start Year
1983
Number of shared co-authors
4
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year
1983
Number of shared co-authors
2
Kenneth C Parker
Washington University
Career Start Year
1982
Number of shared co-authors
2
William W Kwok
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
1982
Number of shared co-authors
6
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year
1981
Number of shared co-authors
11
Wataru Ito
Niigata University of Health and Welfare
Career Start Year
1981
Number of shared co-authors
0
David R Karp
University of Texas Southwestern Medical Center
Career Start Year
1981
Number of shared co-authors
1
Thomas E Fehniger
Biomedical Center, Lund University
Career Start Year
1979
Number of shared co-authors
1
Peter J Munson
and Blood Institute, National Institutes of Health
Career Start Year
1978
Number of shared co-authors
0
Peter S Linsley
8Benaroya Research Institute
Career Start Year
1978
Number of shared co-authors
3
Carl A K Borrebaeck
Lund University
Career Start Year
1977
Number of shared co-authors
2
Dominique Charron
Universite de Strasbourg
Career Start Year
1976
Number of shared co-authors
1
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year
1976
Number of shared co-authors
1
Victor H Engelhard
University of Virginia School of Medicine
Career Start Year
1976
Number of shared co-authors
5
Gerald T Nepom
Wash Benaroya Research Institute at Virginia Mason
Career Start Year
1975
Number of shared co-authors
7
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1971
Number of shared co-authors
1
Leroy Hood
Center for Phenomic Health, The Buck Institute for Research on Aging
Career Start Year
1961
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers
34
Bjoern Peters
University of Washington School of Medicine
Co-authored papers
18
S??ren Brunak
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers
13
Bruce D Walker
Ragon Institute of Mass General
Co-authored papers
12
Jonathan M Carlson
Co-authored papers
7
John Sidney
Co-authored papers
7
Mary Carrington
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers
6
Elizabeth J Phillips
Vanderbilt University Medical Center
Co-authored papers
6
Yann Verdier
PSL University, CNRS UMR9
Co-authored papers
5
Anne S De Groot
University of Georgia
Co-authored papers
5
Jo??lle Vinh
Universite PSL, LPC CNRS UMR8249
Co-authored papers
5
Huynh-Hoa Bui
Co-authored papers
4
Ettore Appella
Co-authored papers
4
William D Martin
EpiVax Inc.
Co-authored papers
4
Julie A McMurry
University of Colorado - Anschutz Medical Campus
Co-authored papers
3
Donald F Hunt
University of Virginia
Co-authored papers
3
Philip E Bourne
University of Virginia
Co-authored papers
3
Decio L Eizirik
Co-authored papers
3
Karsten Skjødt
Co-authored papers
3
Jeffrey Shabanowitz
University of Virginia
Co-authored papers
3
David Heckerman
Co-authored papers
3
Leonard Moise
EpiVax Inc.
Co-authored papers
3
Vishvanath Nene
International Livestock Research Institute (ILRI)
Co-authored papers
3
Yohan Kim
Co-authored papers
3
Anthony W Purcell
Monash Biomedicine Discovery Institute, Monash University
Co-authored papers
2
Jacques Fellay
Ecole Polytechnique Federale de Lausanne
Co-authored papers
2
Steven G Deeks
University of California san francisco
Co-authored papers
2
David W Haas
Vanderbilt University Medical Center
Co-authored papers
2
Daniel Rivera
Center for Natural Products Research, University of Havana
Co-authored papers
2
Jeffrey N Martin
Co-authored papers
2
1 - 30